<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66">
 <label>66.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chêne</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gangnard</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Dechavanne</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Dechavanne</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Srivastava</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Tétard</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Down-selection of the VAR2CSA DBL1-2 expressed in 
   <italic>E. coli</italic> as a lead antigen for placental malaria vaccine development
  </article-title>. 
  <source>NPJ Vaccines</source>. (
  <year>2018</year>) 
  <volume>3</volume>:
  <fpage>28</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41541-018-0064-6</pub-id>
  <?supplied-pmid 30038803?>
  <pub-id pub-id-type="pmid">30038803</pub-id>
 </mixed-citation>
</ref>
